Page last updated: 2024-10-19

oxalic acid and Carcinoma, Non-Small Cell Lung

oxalic acid has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Oxalic Acid: A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.
oxalic acid : An alpha,omega-dicarboxylic acid that is ethane substituted by carboxyl groups at positions 1 and 2.

Research Excerpts

ExcerptRelevanceReference
" IVAA synergy with simultaneous mEHT is safe and the concomitant application significantly increases the plasma AA level for NSCLC patients."2.84The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer. ( Gui, X; Lu, Y; Ou, J; Pang, CLK; Wang, J; Wang, X; Zhang, H; Zhang, T; Zhang, X; Zhao, C; Zhu, X, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ou, J1
Zhu, X1
Lu, Y1
Zhao, C1
Zhang, H1
Wang, X1
Gui, X1
Wang, J1
Zhang, X1
Zhang, T1
Pang, CLK1

Trials

1 trial available for oxalic acid and Carcinoma, Non-Small Cell Lung

ArticleYear
The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2017, Nov-15, Volume: 109

    Topics: Administration, Intravenous; Aged; Ascorbic Acid; Carcinoma, Non-Small-Cell Lung; Combined Modality

2017